David Salzman

Mira Dx, Inc.

$1,999,999

Attributed

$1,999,999

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$1,999,999 · 1

By mechanism

N44$1,999,999 · 1

Top collaborators

No co-investigators on record.

Most similar at Mira Dx, Inc.

Same institution · by research overlap

Richard Gatti$299,957

Others in their field

Other Emerging Leaders on “3&Apos”

Hyacinth Idu Hyacinth · University Of Cincinnati$6,336,090
Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
Jessica Brooke Langbaum · Banner Health$6,050,741
Yi Su · Weill Medical Coll Of Cornell Univ$6,050,741
Craig C Weinkauf · University Of Arizona$5,814,723
Heidi Irma Jacobs · Massachusetts General Hospital$5,549,941

Research focus

3&AposBaseBiological MarkersBiomarker PanelCancer PatientCohortCollectionContractsDiagnostic AssayDistantFailureGeneticGerm-Line MutationHead And Neck CancerHead And Neck Squamous Cell CarcinomaImmuneImmune ResponseIndividual PatientInheritedMalignant Neoplasm Of LungMalignant NeoplasmsMedicalMicrornasNon-Small-Cell Lung Carcinoma

Grant awards (1)

IGF::OT::IGF SBIR Phase II: Topic 338 - Defining Normal Tissue and Tumor Biomarkers of Radiosensitivity to Best Direct Treatment$1,999,999

N44 · FY2017 · CA · contact PI